Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness. (2022)

Peer-Reviewed Study · Natalie S Joe; Inês Godet; Nubaira Milki et al. · December 28, 2022

Natalie S Joe et al., 2022-12-28: Joe et al. show mebendazole reduces primary triple-negative breast tumour size and prevents lung and liver metastases, partly by lowering integrin beta-4 and cancer stemness.

Mice were treated beginning on day 5 with sesame oil as a vehicle gavage and a high-fat KetoCal diet (Con; N = 12), 215 ppm MBZ incorporated into a high-fat KetoCal diet (Feed; N = 7), 20 mg/kg MBZ in a sesame oil gavage (20 mg/kg; N = 6), 30 mg/kg MBZ in a sesame oil gavage (30 mg/kg; N = 12).

Natalie S Joe et al., 2022-12-28: Joe et al. show mebendazole reduces primary triple-negative breast tumour size and prevents lung and liver metastases, partly by lowering integrin beta-4 and cancer stemness. Study type: TNBC cell lines plus mouse metastasis models (N=6-12 per arm as quoted). Country: USA (Johns Hopkins). Dose: 215 ppm in high-fat diet, or 20 mg/kg and 30 mg/kg by oral gavage four times per week. Funder: not stated in the record. Declared conflicts: 'The authors have no competing interests to disclose.' Comparator: vehicle gavage on the same diet. Study type: animal.